HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

317.484

-1.962-0.61%

Number of Gainers:13

Number of Losers:34

Number of Flat:12

PE:- -

High:319.886

Open:319.429

Low:313.595

Close:319.447

Volume:104.60M

Turnover:3.56B

Market Cap:752.35B

Float Cap:670.18B

Loading ...

China's So-Young Q2 Revenue Rises, Net Loss Narrows

China's Rainmed Medical H1 Revenue Rises, Net Loss Narrows

Hong Kong's Lee's Pharmaceutical H1 Profit Jumps on Higher-Margin Product Sales

Lee's Pharm Reports 41.4% Profit Surge in H1 Results

Chaoju Eye Care Allocates Approximately HK$2.08 Million to Repurchase 873,500 Shares on August 31

Chaoju Eye Care Files HKEX Next-Day Return Disclosing Share Repurchase for Cancellation

BETTERLIFE HLDG (06909) Swings to Interim Loss Amid Revenue Dip

BetterLife Holding H1 Revenue RMB 3,852.6 Million

THOMSON REUTERS

BetterLife Holding Ltd - Board Proposed not to Declare Any Interim Dividend

THOMSON REUTERS

BetterLife Turns to H1 FY26 Net Loss of RMB 107.3 Million; Revenue Rises 1% to RMB 3.85 Billion

China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth

Shanghai HeartCare Medical Technology - Board Did not Declare the Payment of an Interim Dividend

THOMSON REUTERS

Shanghai HeartCare H1 FY26 Profit Climbs 18.5% to RMB 60.37 Million; Revenue Rises 56.9% to RMB 291.03 Million

Shanghai HeartCare Medical Technology H1 Revenue RMB 291 Million

THOMSON REUTERS

Hong Kong Stocks Edge Lower on Monday Amid Middle East Tensions; HUTCHMED Falls 2%

MT Newswires Live

Hutchmed Says Savolitinib Plus AstraZeneca’s Tagrisso Extends PFS in China Phase III Sanovo Lung Cancer Trial

Rebuilding Foundations: How KANGQIAO SER Charts a Quality-Driven Path in a Shifting Property Market

Hong Kong Stock Alert | Chaoju Eye Care Drops Over 7% After Interim Net Profit Declines 16.65%

HUTCHMED Sees Positive High Level Results in Lung Cancer Drug Combo Trial

MT Newswires Live

Hutchmed (China) - Announces Positive Results from Sanovo China Phase Trial in Nsclc Patients

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK1587/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1587","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","market":"HK","secType":"PLATE","nameCN":"Sub-New Stocks","latestPrice":317.4844,"timestamp":1789114133774,"preClose":319.44687,"halted":0,"volume":104597924,"delay":0,"changeRate":-0.006143,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-1.962463,"latestTime":"09-11 16:00:00","open":319.42862,"high":319.88553,"low":313.59467,"amount":3559134410.4,"amplitude":0.019693,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.339379,"peRate":15.260692,"turnoverRate":0.002002,"increases":12,"decrements":36,"flats":10,"marketCap":752353199316,"floatMarketCap":670179486148},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","high":319.88553,"amplitude":0.019693,"preClose":319.44687,"low":313.59467,"pbRate":"1.339379","latestPrice":317.4844,"volume":104597924,"delay":0,"open":319.42862,"prevYearClose":478.5753,"prevWeekClose":332.269,"prevMonthClose":342.657,"prevQuarterClose":326.657,"fiveDayClose":332.269,"twentyDayClose":346.279,"sixtyDayClose":361.102,"secType":"PLATE","market":"HK","turnoverRate":0.002002,"peRate":15.260692,"marketCap":752353199316,"floatMarketCap":670179486148,"timestamp":1789114133774,"nameCN":"Sub-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1587\",,,,undefined,":{"bkCode":"BK1587","up":13,"down":34,"flat":12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1587\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663878074","title":"China's So-Young Q2 Revenue Rises, Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2663878074","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663878074?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:11","pubTimestamp":1788171110,"startTime":"0","endTime":"0","summary":"China's So-Young Q2 revenue rises, net loss narrowsOverviewChina aesthetic treatment platform's Q2 revenue rose 33% yr/yr, driven by branded center expansionNet loss for Q2 narrowed yr/yr, reflecting ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0BC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK1574","06609","BK1587","SY","BK4077","BK4503","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071777","title":"China's Rainmed Medical H1 Revenue Rises, Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071777","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071777?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:08","pubTimestamp":1788170928,"startTime":"0","endTime":"0","summary":"China's Rainmed Medical H1 revenue rises, net loss narrowsOverviewChina medical device maker's H1 revenue rose 41% yr/yr, driven by caFFR system salesNet loss attributable to shareholders narrowed to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0BA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","06609","BK1191","01228","BK1587","BK1100","01477","02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663437071","title":"Hong Kong's Lee's Pharmaceutical H1 Profit Jumps on Higher-Margin Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2663437071","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663437071?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:00","pubTimestamp":1788170409,"startTime":"0","endTime":"0","summary":"Hong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product salesOverviewHong Kong pharma maker's interim revenue grew 14.6% yr/yr for six months ended June 2026Net income attributable t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1583","BK1515","06622","01477","BK1587","00570","BK1191","BK1574","00950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121505356","title":"Lee's Pharm Reports 41.4% Profit Surge in H1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1121505356","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121505356?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:54","pubTimestamp":1788170056,"startTime":"0","endTime":"0","summary":"LEE'S PHARM (00950) has announced its interim results for 2026, posting a revenue of approximately HK$797 million, marking a year-on-year increase of 14.6%.The company recorded a profit attributable...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00950","BK1191","06622","BK1587","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166332312","title":"Chaoju Eye Care Allocates Approximately HK$2.08 Million to Repurchase 873,500 Shares on August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1166332312","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166332312?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:54","pubTimestamp":1788170055,"startTime":"0","endTime":"0","summary":"On August 31, 2026, Chaoju Eye Care (02219) announced that it had repurchased 873,500 shares at a total cost of approximately HK$2.0774 million, with the buyback price ranging from HK$2.355 to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","02219","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804071","title":"Chaoju Eye Care Files HKEX Next-Day Return Disclosing Share Repurchase for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804071","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663804071?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169889,"startTime":"0","endTime":"0","summary":"Chaoju Eye Care files HKEX next-day return disclosing share repurchase for cancellationChaoju Eye Care repurchased 873,500 ordinary shares on Aug. 31 for cancellation, per its HKEX next-day disclosure","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL2WhSVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1209","02219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149496604","title":"BETTERLIFE HLDG (06909) Swings to Interim Loss Amid Revenue Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=1149496604","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149496604?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:30","pubTimestamp":1788168613,"startTime":"0","endTime":"0","summary":"BETTERLIFE HLDG (06909) has released its results for the six months ended June 30, 2026, revealing a shift from profitability to a net loss. The company reported a loss attributable to shareholders...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1239","06909","BK1587","BK1520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663761940","title":"BetterLife Holding H1 Revenue RMB 3,852.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663761940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663761940?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:16","pubTimestamp":1788167808,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nPLXGF9WPH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06909","BK1587","BK1239","BK1520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076152","title":"BetterLife Holding Ltd - Board Proposed not to Declare Any Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076152?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:16","pubTimestamp":1788167785,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R05A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1520","06909","BK1239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663761630","title":"BetterLife Turns to H1 FY26 Net Loss of RMB 107.3 Million; Revenue Rises 1% to RMB 3.85 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2663761630","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663761630?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:16","pubTimestamp":1788167762,"startTime":"0","endTime":"0","summary":"BetterLife turns to H1 FY26 net loss of RMB 107.3 million; revenue rises 1% to RMB 3.85 billionBetterLife posted a net loss of RMB 107.3 million, swinging from profit; basic loss per share was RMB 0.1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL3kYzGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1239","06909","BK1520","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663928076","title":"China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2663928076","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663928076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:14","pubTimestamp":1788167685,"startTime":"0","endTime":"0","summary":"China's HeartCare Medical H1 revenue surges on stroke segment growthOverviewChina medical device maker's H1 revenue rose 56.9% yr/yr to RMB291 mlnNet profit attributable to shareholders grew 18.5% yr/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S09G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0097","BK1191","01477","600085","BK0028","BK1587","06609","BK0239","BK0183","BK0012","BK1606","06622","BK1100","01666","BK1574","BK0196","LU1688375341.USD","BK1515","BK0113","BK1583","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663763580","title":"Shanghai HeartCare Medical Technology - Board Did not Declare the Payment of an Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2663763580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663763580?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166975,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R07R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06609","BK1587","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076351","title":"Shanghai HeartCare H1 FY26 Profit Climbs 18.5% to RMB 60.37 Million; Revenue Rises 56.9% to RMB 291.03 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076351","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076351?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166937,"startTime":"0","endTime":"0","summary":"Shanghai HeartCare H1 FY26 profit climbs 18.5% to RMB 60.37 million; revenue rises 56.9% to RMB 291.03 millionShanghai HeartCare posted revenue of RMB 291.03 million, up 56.9% year over year; profit a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL636RtR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1100","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076331","title":"Shanghai HeartCare Medical Technology H1 Revenue RMB 291 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076331?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166936,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nPLXBXPQPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1587","BK1574","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075066","title":"Hong Kong Stocks Edge Lower on Monday Amid Middle East Tensions; HUTCHMED Falls 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663075066?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:59","pubTimestamp":1788166745,"startTime":"0","endTime":"0","summary":"Hong Kong stocks closed slightly lower on Monday as renewed U.S.-Iran fighting pushed oil prices higher and added to concerns over inflation and interest rates.The Hang Seng Index fell 17.80 points, o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["07500","03115","HCM","HSI","BK1588","BK1191","BK1587","513600","HHImain","82800","02800","MHImain","03419","07300","HSTECH","03037","83115","07200","02833","00013","09115","MCHmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663020106","title":"Hutchmed Says Savolitinib Plus AstraZeneca’s Tagrisso Extends PFS in China Phase III Sanovo Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663020106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663020106?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:15","pubTimestamp":1788160521,"startTime":"0","endTime":"0","summary":"HUTCHMED says savolitinib plus AstraZeneca’s Tagrisso extends PFS in China Phase III SANOVO lung cancer trialHUTCHMED reported positive high-level results from the SANOVO China Phase III trial in firs","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL8xkCdp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BQXX3F31.USD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","BK1191","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LU2210150020.SGD","NDAQ","SG9999014005.SGD","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4588","BK4112","SG9999014021.USD","IE00BN0W2W23.USD","BK1588","BK1587","00013","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140895782","title":"Rebuilding Foundations: How KANGQIAO SER Charts a Quality-Driven Path in a Shifting Property Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1140895782","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140895782?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:04","pubTimestamp":1788159865,"startTime":"0","endTime":"0","summary":"As the real estate sector navigates its most profound adjustment in years, the investment narrative for Hong Kong-listed property management firms has undergone a complete transformation. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1258","BK1542","BK1229","BK1587","02205"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114884883","title":"Hong Kong Stock Alert | Chaoju Eye Care Drops Over 7% After Interim Net Profit Declines 16.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114884883","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114884883?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:42","pubTimestamp":1788158547,"startTime":"0","endTime":"0","summary":"Shares of Chaoju Eye Care (02219) fell more than 7% in Hong Kong trading, with the stock last down 7.28% at HK$2.355, on turnover of HK$4.907 million.According to the company's interim results for...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","VXUS","BK4585","02219","KCAI","BK4588","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663579022","title":"HUTCHMED Sees Positive High Level Results in Lung Cancer Drug Combo Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663579022","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663579022?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:39","pubTimestamp":1788154752,"startTime":"0","endTime":"0","summary":"HUTCHMED   announced positive high-level results from its SANOVO China phase  trial in treatment-nave patients with non-small cell lung cancer, according to a Monday Hong Kong bourse filing.ORPATHYS plus TAGRSSO significantly improved progression-free survival versus TAGRSSO alone in both high MET and intention-to-treat patient populations.The combination also showed an encouraging clinical benefit in overall survival in both populations, which was a secondary endpoint of the trial.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1587","BK1588","00013"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028693","title":"Hutchmed (China) - Announces Positive Results from Sanovo China Phase Trial in Nsclc Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663028693?lang=en_us&edition=fundamental","pubTime":"2026-08-31 08:00","pubTimestamp":1788134458,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1588","00013","BK1587"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":11,"totalSize":269,"code":"91000000","status":"200"}]}}